Key facts
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for Heyuan Biotechnology
- ·The full record, as it builds
Funding rounds
No funding rounds for Heyuan Biotechnology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Heyuan Biotechnology
Developer of biotechnology applications intended for medical institutions, research organizations, and healthcare innovators seeking to apply emerging technologies in diagnostics, therapeutics, and health management. The company is engaged in research and development services focused on transforming technologies into practical healthcare solutions, thereby enabling clients to gain access to a platform that accelerates the transformation of scientific breakthroughs into usable medical solutions.
- Sector
- Healthcare
- HQ
- Shanghai, China
- Founded
- 2025
- Ownership
- Privately Held (backing)
Heyuan Biotechnology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Heyuan Biotechnology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Heyuan Biotechnology in its N-PORT filings yet. We sweep new filings monthly.